Online citations, reference lists, and bibliographies.
← Back to Search

Longitudinal Time Course Of Reversible And Irreversible Components Of Chronic Cerebrovasospasm Of The Rabbit Basilar Artery.

P. Vorkapic, R. Bevan, J. Bevan
Published 1991 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Multiple injections of autologous blood were made around the basilar artery of rabbits through a silicone catheter placed into the prepontine cistern. The total blood injected was 3 ml/kg in aliquots of 0.5 to 0.8 ml over a 4-hour period. Control angiograms were obtained 7 days before this procedure. Groups of animals were examined by angiography on each of 9 days after the injections of blood. An angiogram was obtained 15 minutes after the first injection of blood, 20 seconds after the intra-arterial injection of a maximum dilating dose of papaverine. All surviving animals showed basilar artery narrowing, which was greatest 24 hours after the hemorrhage, when the vessel diameter was reduced to 54% of the control value. The narrowing then decreased to a reduction of about 30%, which was maintained throughout the rest of the study period. A papaverine-resistant component of narrowing was not seen until the 3rd day. It increased progressively to Day 9 when it represented 63% of the total. This model has a number of features that are reminiscent of human cerebrovasospasm, including the fact that there is an initial phase of narrowing that is completely reversed by an intra-arterially administered vasodilator, and a second phase beginning on Day 3 which exhibits a progressively increasing papaverine-resistant component.
This paper references
10.3171/JNS.1983.58.1.0011
Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model.
V. Varsos (1983)
10.3171/JNS.1986.64.2.0292
Ultrastructural evidence of arterial denervation following experimental subarachnoid hemorrhage.
T. Duff (1986)
10.1016/S0025-6196(12)60441-8
Cerebral vasospasm after subarachnoid hemorrhage.
D. Chyatte (1984)
10.1227/00006123-198601000-00001
Chronic cerebral vasospasm: effect of volume and timing of hemorrhage in a canine model.
J. Zabramski (1986)
10.3171/JNS.1974.40.4.0459
The role of mechanical factors in the pathogenesis of short-term and prolonged spasm of the cerebral arteries.
A. Arutiunov (1974)
10.1227/00006123-198502000-00008
Arterial wall changes in early human vasospasm.
R. Smith (1985)
10.1161/01.STR.13.5.595
Experimental cerebral vasospasm arterial wall mechanics and connective tissue composition.
S. Nagasawa (1982)
10.3171/JNS.1984.61.3.0494
Intimal proliferation of cerebral arteries after subarachnoid blood injection in pigs.
T. Takemae (1984)
10.3171/JNS.1989.71.3.0430
Alterations of mechanical properties in canine basilar arteries after subarachnoid hemorrhage.
P. Kim (1989)
10.3171/JNS.1977.46.3.0296
Cerebrovascular sensitivity to vasoconstricting agents induced by subarachnoid hemorrhage and vasospasm in dogs.
N. Toda (1977)
10.1161/01.STR.11.6.601
Intra‐Arterial Nitroprusside Treatment of Acute Experimental Vasospasm
L. Hirsh (1980)
10.3171/JNS.1989.70.5.0732
Transcranial Doppler sonography within 12 hours after subarachnoid hemorrhage.
B. Romner (1989)
10.3171/JNS.1983.58.1.0018
Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall.
T. Liszczak (1983)
Increased sensitivity of the basilar artery to norepinephrine and 5-hydroxytryptamine following experimental subarachnoid hemorrhage.
N. A. Svendgaard (1977)
10.1016/0090-3019(87)90280-1
Angiographic evidence of basilar artery constriction in the rabbit: a new model of vasospasm.
K. Baker (1987)
10.3171/JNS.1982.57.2.0224
Chronic cerebral vasospasm after large subarachnoid hemorrhage in monkeys.
F. Espinosa (1982)
10.1161/01.STR.16.4.595
Subarachnoid haemorrhage in the rat: angiography and fluorescence microscopy of the major cerebral arteries.
T. Delgado (1985)
10.1161/01.STR.20.8.1021
Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high-dose methylprednisolone.
D. Chyatte (1989)
10.3171/JNS.1981.55.6.0865
Intravenous nitroglycerin for the treatment of chronic cerebral vasoconstriction in the primate.
J. Frazee (1981)
10.1161/01.STR.16.6.990
Altered membrane properties of cerebral vascular smooth muscle following subarachnoid hemorrhage: an electrophysiological study. I. Changes in resting membrane potential (Em) and effect on the electrogenic pump potential contribution to Em.
A. Waters (1985)
10.3171/JNS.1975.42.4.0420
Experimental cerebral vasospasm. Part 2: effects of vasoactive drugs and sympathectomy on early and late spasm.
H. Nagai (1975)
10.1161/01.STR.10.1.26
Intravenous Nitroglycerin in Experimental Cerebral Vasospasm. A Preliminary Report
J. Kistler (1979)
10.3171/JNS.1974.41.4.0440
Experimental catecholamine-induced chronic cerebral vasospasm. Myonecrosis in vessel wall.
J. Alksne (1974)
10.1016/0002-9149(85)90538-7
Experimental chronic cerebrovascular spasm in the monkey: an assessment of the functional changes in the cerebral arteries and their protection by diltiazem.
J. Bevan (1985)
10.1227/00006123-198002000-00016
Attempted prevention or treatment of intracranial arterial spasm: a survey.
R. Wilkins (1980)
10.1161/01.STR.3.1.49
A Model for Experimental Cerebral Arterial Spasm
A. Kuwayama (1972)
10.1146/ANNUREV.PA.28.040188.001523
Arterial wall changes in chronic cerebrovasospasm: in vitro and in vivo pharmacological evidence.
J. Bevan (1988)
10.3171/JNS.1978.48.2.0173
Time course of vasospasm in man.
B. Weir (1978)
10.3171/JNS.1974.41.1.0049
Sequential changes of vascular ultrastructure in experimental cerebral vasospasm. Myonecrosis of subarachnoid arteries.
J. Fein (1974)
10.1161/01.STR.18.2.472
Functional arterial changes in chronic cerebrovasospasm in monkeys: an in vitro assessment of the contribution to arterial narrowing.
J. Bevan (1987)
10.1161/01.STR.21.10.1478
Pharmacologic irreversible narrowing in chronic cerebrovasospasm in rabbits is associated with functional damage.
P. Vorkapic (1990)
10.1136/bmj.298.6674.636
Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.
J. Pickard (1989)
10.3171/JNS.1980.53.4.0480
Cerebrovascular reactivity to noradrenaline and serotonin following experimental subarachnoid hemorrhage.
R. Lobato (1980)
10.1227/00006123-198708000-00004
Preliminary report: effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage.
D. Chyatte (1987)
10.1227/00006123-198609000-00002
Reactivity of rabbit basilar artery to alterations in extracellular potassium and calcium after subarachnoid hemorrhage.
H. Young (1986)
10.3171/JNS.1978.48.4.0515
Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage.
J. T. Hughes (1978)



This paper is referenced by
10.1007/978-3-7091-6232-3_23
The effect of sympathetic nervous system exclusion on cerebral vasospasm following subarachnoid hemorrhage in rabbits.
G. Bunc (2001)
10.1007/s00701-003-0024-3
Changes in vascular responses of the basilar artery to acetylcholine and endothelin-1 in an experimental rabbit vasospasm model
C. Kim (2003)
10.3171/JNS.1992.77.6.0848
Treatment of cerebral vasospasm with intra-arterial papaverine.
N. Kassell (1992)
10.1161/01.STR.21.10.1478
Pharmacologic irreversible narrowing in chronic cerebrovasospasm in rabbits is associated with functional damage.
P. Vorkapic (1990)
10.3171/JNS.2000.92.3.0390
Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage.
S. Juvela (2000)
10.1161/01.STR.27.2.311
Relaxation of subarachnoid hemorrhage-induced spasm of rabbit basilar artery by the K+ channel activator cromakalim.
M. Zuccarello (1996)
10.1152/AJPHEART.00911.2005
Calcium sensitivity of vasospastic basilar artery after experimental subarachnoid hemorrhage.
R. Macdonald (2006)
Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH.
S. Hendryk (2004)
10.1016/j.autneu.2006.05.002
Correspondence between the time course of cerebral vasospasm and the level of cerebral dopamine-β-hydroxylase in rabbits
S. Kovačič (2006)
10.1007/978-3-7091-6232-3_24
Comparison of cerebral vasospasm between young and old animals: preliminary report.
I. Date (2001)
10.1016/j.jneumeth.2008.03.020
Induction of housekeeping gene expression after subarachnoid hemorrhage in dogs
Y. Aihara (2008)
10.1007/978-3-540-72304-2_6
Molecular Biology and Genetics
M. Wetzler (2008)
10.1054/jocn.2001.1036
The efficacy of papaverine administration by different routes for the treatment of experimental acute cerebral vasospasm
H. Liu (2002)
10.1007/BF03040471
The influence of noradrenergic blockade on vasospasm and the quantity of cerebral dopamine ß-hydroxylase following subarachnoid haemorrhage in rabbits
G. Bunc (2009)
10.1016/0967-5868(94)90012-4
Effects of intrathecal administration of nicardipine and nifedipine on chronic cerebral vasospasm in dogs
M. Shibuya (1994)
10.1385/NCC:5:3:215
Role of vascular mitogens in subarachnoid hemorrhage-associated cerebral vasculopathy
C. A. Miller (2006)
10.1016/S1566-0702(01)00327-7
Evaluation of functional response of cerebral arteries by a new morphometric technique
G. Bunc (2001)
Associated With Functional Damage
P. Vorkapic (2005)
10.1111/j.1365-2990.1995.tb01074.x
Superoxide anions in the pathogenesis of talc‐induced cerebraI vasocontraction
T. Mori (1995)
10.3171/JNS.2000.93.3.0463
Subarachnoid hemorrhage as a cause of an adaptive response in cerebral arteries.
M. Stoodley (2000)
10.1227/00006123-199604000-00029
Intracellular calcium, myosin light chain phosphorylation, and contractile force in experimental cerebral vasospasm.
W. E. Bulter (1996)
10.3171/FOC.2006.21.3.16
Effect of intraarterial papaverine and/or angioplasty on the cerebral veins in patients with vasospasm after subarachnoid hemorrhage due to ruptured intracranial aneurysms.
A. A. Elsayed (2006)
10.1161/01.STR.28.10.2031
Inhibition of experimental vasospasm with anti-intercellular adhesion molecule-1 monoclonal antibody in rats.
E. M. Oshiro (1997)
10.1007/978-1-4419-9530-8_29
Animal Models of SAH and Their Translation to Clinical SAH
T. Zoerle (2012)
10.1097/00006123-199310000-00023
Procollagen types I and III and transforming growth factor-beta gene expression in the arterial wall after exposure to periarterial blood.
H. Kasuya (1993)
10.1007/978-3-7091-6232-3_2
Pathophysiology and molecular genetics of vasospasm.
R. Macdonald (2001)
10.1097/00006123-200209000-00027
Intracisternal Sodium Nitroprusside Fails to Prevent Vasospasm in Nonhuman Primates
R. Macdonald (2002)
10.1016/B978-012464161-7/50013-5
Chapter 11 – Animal Models
R. Macdonald (2001)
Endovascular Treatment of Cerebral Vasospasm 1
T. Smith (2000)
10.1227/00006123-199511000-00016
Papaverine-sensitive vasospasm and arterial contractility and compliance after subarachnoid hemorrhage in dogs.
R. Macdonald (1995)
10.1016/S0165-0270(02)00344-8
A murine model of subarachnoid hemorrhage-induced cerebral vasospasm
C. Lin (2003)
10.2335/SCS.29.245
Treatment for Poor-grade Patients with Severe Subarachnoid Hemorrhage. Clinical Results for the Severe Subarachnoid Hemorrhage: Analysis of the Improvement in the Last Five Years.
K. Nagata (2001)
See more
Semantic Scholar Logo Some data provided by SemanticScholar